Standard versus continuous administration of capecitabine in metastatic breast cancer (GEICAM/2009-05): a randomized, noninferiority phase II trial with a pharmacogenetic analysis
![Thumbnail](/xmlui/bitstream/handle/11531/6458/Dataset%20Geicam%202009-05.pdf.jpg?sequence=2&isAllowed=y)
View/ Open
Date
19/01/2015Author
Estado
info:eu-repo/semantics/publishedVersionMetadata
Show full item recordAbstract
. .
Standard versus continuous administration of capecitabine in metastatic breast cancer (GEICAM/2009-05): a randomized, noninferiority phase II trial with a pharmacogenetic analysis
Tipo de Actividad
Artículos en revistasISSN
1083-7159Palabras Clave
..